- Report
- February 2025
- 200 Pages
Global
From €4029EUR$4,490USD£3,467GBP
- Report
- June 2024
- 79 Pages
United States
From €2332EUR$2,599USD£2,007GBP
- Report
- April 2023
- 175 Pages
Global
From €5293EUR$5,899USD£4,556GBP
- Report
- November 2023
- 30 Pages
Global
From €2468EUR$2,750USD£2,124GBP
- Report
- February 2024
- 77 Pages
Global
From €3500EUR$4,178USD£3,118GBP
- Report
- April 2025
- 50 Pages
Global
From €2378EUR$2,650USD£2,047GBP
- Book
- July 2023
- 1568 Pages
- Book
- July 2015
- 328 Pages
Metronidazole is an antibiotic used to treat a variety of bacterial and protozoal infections. It is a nitroimidazole, which works by inhibiting the growth of bacteria and protozoa. It is commonly used to treat infections of the gastrointestinal tract, skin, and vagina. It is also used to treat anaerobic bacterial infections, such as those caused by Bacteroides fragilis. Metronidazole is available in both oral and topical forms.
Metronidazole is a widely used antibiotic, and is available in generic and branded forms. It is available in a variety of strengths and formulations, including tablets, capsules, creams, and gels. It is also available in combination with other antibiotics, such as amoxicillin and clindamycin.
Metronidazole is used to treat a variety of bacterial and protozoal infections, and is an important part of the antibiotic market. It is used in both hospital and community settings, and is an important part of the treatment of many infections.
Some companies in the Metronidazole market include Pfizer, Merck, Sanofi, GlaxoSmithKline, and Novartis. Show Less Read more
